Get started
Author

Meena Shri

Observed institution: National Dairy Research Institute
ORCID: 0009-0003-9588-6034
Observed ORCID: 0009-0003-9588-6034
OpenAlex ID: A5080610600
Hanging Drop, A Best Three-Dimensional (3D) Culture Method for Primary Buffalo and Sheep Hepatocytes
2017 · Meena Shri, Himanshu Agrawal, et al. · Scientific Reports · 80
PDF
BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth
2023 · Srinivas Reddy Boreddy, Reshmi Nair, et al. · Cancer Research · 40
PDF
874 Development of BCA101, a bifunctional antibody capable of simultaneously disabling EGFR and TGFβ signaling, as novel single-agent immunotherapy
2021 · Srinivas Reddy Boreddy, Reshmi Nair, et al. · Journal for ImmunoTherapy of Cancer · 3
PDF
Supplementary Data from BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth
2025 · Srinivas Reddy Boreddy, Reshmi Nair, et al.
Supplementary Data from BCA101 is a Tumor-Targeted Bifunctional Fusion Antibody that Simultaneously Inhibits EGFR and TGF-β Signalling to Durably Suppress Tumor Growth
2024 · Srinivas Reddy Boreddy, Reshmi Nair, et al.
Data from BCA101 is a Tumor-Targeted Bifunctional Fusion Antibody that Simultaneously Inhibits EGFR and TGF-β Signalling to Durably Suppress Tumor Growth
2024 · Srinivas Reddy Boreddy, Reshmi Nair, et al.
Supplementary Data from BCA101 is a Tumor-Targeted Bifunctional Fusion Antibody that Simultaneously Inhibits EGFR and TGF-β Signalling to Durably Suppress Tumor Growth
2024 · Srinivas Reddy Boreddy, Reshmi Nair, et al.
Supplementary Data from BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth
2023 · Srinivas Reddy Boreddy, Reshmi Nair, et al.
Data from BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth
2023 · Srinivas Reddy Boreddy, Reshmi Nair, et al.
Supplementary Data from BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth
2023 · Srinivas Reddy Boreddy, Reshmi Nair, et al.
Works count: 10
Citation count: 123
H-index: 3
I10-index: 2
Year
Topic
Type